Articles

U.S. CoreValve High Risk trial TCT 2014

According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful clinical benefits relative to surgical aortic valve replacement (SAVR) in high risk patients with...

Mr. KH is a 58-year-old male with a past medical history of hypertension and tobacco abuse who presented to the  emergency department (ED) with an episode of syncope. The patient stated that...

3-d pronting, 3D printing

The FDA has recognized 3-D printing technology now exists to print medical devices and is gathering information regarding technical assessments that should be considered when it will inevitably...

May 2, 2014 — Medtronic Inc. revealed new data demonstrating positive outcomes for extreme risk patients with severe aortic stenosis who were treated with the CoreValve system via alternative...

Corevalve beats surgery, ACC 2014, TAVR vs surgery, Edwards lawsuit

The U.S. District Court for the District of Delaware granted a preliminary injunction limiting the sale of Medtronic's CoreValve transcatheter aortic valve replacement (TAVR) system in the United...

Boston Scientific Lotus Aortic Valve Repair Heart Hybrid OR Cath Lab

Boston Scientific’s Lotus transcatheter aortic valve repair (TAVR) system was implanted for the first...

TAVR Heart valve repair Hybrid OR

A team of interventional cardiologists and cardiovascular surgeons at The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann Heart & Vascular Institute-Texas...

Edwards Lifesciences Sapien Transcatheter Aortic Valve Heart Repair Structural

Doctors at Henry Ford Hospital in Detroit used an Edwards Lifesciences Sapien transcatheter aortic valve...

Medtronic Corevalve, FDA

The U.S. Food and Drug Administration (FDA) granted U.S. market approval for Medtronic’s self-expanding transcatheter aortic...

ACC, iPad cardiology apps

DAIC readers chose the following stories as the most popular content in 2013, based on website analytics.